BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32203166)

  • 1. Long noncoding RNA CMPK2 promotes colorectal cancer progression by activating the FUBP3-c-Myc axis.
    Gao Q; Zhou R; Meng Y; Duan R; Wu L; Li R; Deng F; Lin C; Zhao L
    Oncogene; 2020 May; 39(19):3926-3938. PubMed ID: 32203166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
    Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.
    Yang Z; An Y; Wang N; Dong X; Kang H
    J Cell Physiol; 2020 Oct; 235(10):7449-7464. PubMed ID: 32064615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer.
    Huang W; Tian Y; Dong S; Cha Y; Li J; Guo X; Yuan X
    Oncol Rep; 2017 Sep; 38(3):1402-1410. PubMed ID: 28731158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long noncoding RNA LUCAT1 promotes colorectal cancer cell proliferation by antagonizing Nucleolin to regulate MYC expression.
    Wu R; Li L; Bai Y; Yu B; Xie C; Wu H; Zhang Y; Huang L; Yan Y; Li X; Lin C
    Cell Death Dis; 2020 Oct; 11(10):908. PubMed ID: 33097685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.
    Ma Z; Gu S; Song M; Yan C; Hui B; Ji H; Wang J; Zhang J; Wang K; Zhao Q
    Mol Biosyst; 2017 Oct; 13(11):2350-2361. PubMed ID: 28933484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression.
    Ding J; Li J; Wang H; Tian Y; Xie M; He X; Ji H; Ma Z; Hui B; Wang K; Ji G
    Cell Death Dis; 2017 Aug; 8(8):e2997. PubMed ID: 28796262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
    Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long noncoding RNA TPTE2P1 promotes the viability of colorectal cancer cells.
    Dai X; Xie Y; Dong M; Zhao J; Yu H; Zhou B; Xu Y; Yu Y; Cao Y; Zhang Y
    J Cell Biochem; 2019 Apr; 120(4):5268-5276. PubMed ID: 30382596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological functions and clinical significance of the newly identified long non‑coding RNA RP1‑85F18.6 in colorectal cancer.
    Ma Y; Chen Y; Lin C; Hu G
    Oncol Rep; 2018 Nov; 40(5):2648-2658. PubMed ID: 30226619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
    Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
    Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LNRRIL6, a novel long noncoding RNA, protects colorectal cancer cells by activating the IL-6-STAT3 pathway.
    Wang J; Zhou J; Jiang C; Zheng J; Namba H; Chi P; Asakawa T
    Mol Oncol; 2019 Nov; 13(11):2344-2360. PubMed ID: 31246342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m
    Ni W; Yao S; Zhou Y; Liu Y; Huang P; Zhou A; Liu J; Che L; Li J
    Mol Cancer; 2019 Oct; 18(1):143. PubMed ID: 31619268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.
    Yang P; Chen T; Xu Z; Zhu H; Wang J; He Z
    Oncotarget; 2016 Jul; 7(27):42183-42194. PubMed ID: 27259250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.